Social network-based group intervention to promote HIV prevention in Uganda: study protocol for a cluster randomized controlled trial of Game Changers.
Social network-based group intervention to promote HIV prevention in Uganda: study protocol for a cluster randomized controlled trial of Game Changers.
复制标题
基于社会网络的群体干预促进乌干达艾滋病毒预防:游戏规则改变者的整群随机对照试验的研究方案。
DOI:
10.1186/s13063-022-06186-z
复制
发表时间:
2022-03-28
期刊:
影响因子:
2.5
通讯作者:
Okoboi S
中科院分区:
文献类型:
--
作者:
Wagner GJ;Bogart LM;Green HD;Storholm ED;Klein DJ;McBain RK;Serunkuuma R;Mubiru K;Matovu JKB;Okoboi S
Innovative strategies are needed to disseminate HIV prevention messages across communities efficiently, as well as reduce HIV stigma while promoting HIV prevention. This randomized controlled trial will evaluate the efficacy of a social network-based group intervention, Game Changers, which trains persons living with HIV (PLWH) to encourage members of their social network to use HIV protective behaviors PLWH in HIV care for at least 1 year will be randomly assigned to receive the 8-session group advocacy training intervention or no-intervention control group. Each enrolled PLWH (index participant) will be asked to recruit up to four social network members (alter participant). Assessments will be administered at baseline and months 6, 12, and 18 to both index and alter participants. The primary outcomes are HIV testing and condom use among alter participants; secondary outcomes are engagement in HIV prevention advocacy and internalized HIV stigma among index participants. Repeated-measures multivariable regression analyses will be conducted to compare outcomes between the intervention and control arms, in addition to a cost-effectiveness evaluation. This social network-based approach to HIV prevention is particularly timely in the era of biomedical interventions, which require widespread penetration of effective HIV prevention and care messaging into communities. Positioning PLWH as central to the solution for controlling (vs. causing) the HIV epidemic has the potential to reduce HIV stigma and improve prevention outcomes at the individual and network levels. ClinicalTrials.gov NIH Clinical Trial Registry NCT05098015. Registered on October 18, 2021.
登录
查看更多内容
DOI:
10.1097/qai.0000000000001886
发表时间:
2019-01-01
影响因子:
3.6
作者:
Mustanski, Brian;Morgan, Ethan;Newcomb, Michael E.
通讯作者:
Newcomb, Michael E.
DOI:
10.1016/s0140-6736(15)60095-2
发表时间:
2015-07-11
期刊:
Lancet (London, England)
影响因子:
--
作者:
Kim DA;Hwong AR;Stafford D;Hughes DA;O'Malley AJ;Fowler JH;Christakis NA
通讯作者:
Christakis NA
影响因子:
5.4
作者:
Hedges, Larry V.;Citkowicz, Martyna
通讯作者:
Citkowicz, Martyna
影响因子:
4.2
作者:
Kaponda, Chrissie P. N.;Norr, Kathleen F.;Dancy, Barbara L.
通讯作者:
Dancy, Barbara L.
DOI:
10.1136/bmj.e7586
发表时间:
2013-01-08
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Chan AW;Tetzlaff JM;Gøtzsche PC;Altman DG;Mann H;Berlin JA;Dickersin K;Hróbjartsson A;Schulz KF;Parulekar WR;Krleza-Jeric K;Laupacis A;Moher D
通讯作者:
Moher D